Compile Data Set for Download or QSAR
maximum 50k data
Found 47 with Last Name = 'hatakeyama' and Initial = 'y'
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110571(CHEMBL167991 | FR-230481 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  0.540nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110562(5-Chloro-3-(2-{4-[(3-methoxy-6,7,8,9-tetrahydro-5H...)
Affinity DataIC50:  0.700nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110567(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110569(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  1.20nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110565(CHEMBL164873 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  3.70nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110573(3-Chloro-N-[2-(4-{[(1-hydroxy-7-methoxy-1,2,3,4-te...)
Affinity DataIC50:  11nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110572(CHEMBL167860 | N-[2-(4-{[(1-Hydroxy-7-methoxy-1,2,...)
Affinity DataIC50:  13nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110416(CHEMBL350620 | FR-226928 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  16nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110416(CHEMBL350620 | FR-226928 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  16nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110570(CHEMBL166399 | Naphthalene-1-sulfonic acid [2-(4-{...)
Affinity DataIC50:  24nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110564(5-Chloro-3-[2-(4-{[(1-hydroxy-7-methoxy-1,2,3,4-te...)
Affinity DataIC50:  28nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110415(CHEMBL164897 | Naphthalene-1-sulfonic acid (4-{[(1...)
Affinity DataIC50:  38nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110417(CHEMBL351508 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  39nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110407(CHEMBL162093 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  45nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110414(CHEMBL164586 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  52nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110568(1-[2-(5-Chloro-2-oxo-benzothiazol-3-yl)-acetyl]-pi...)
Affinity DataIC50:  53nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110566(CHEMBL167621 | Naphthalene-1-sulfonic acid [2-(4-{...)
Affinity DataIC50:  56nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110563(CHEMBL354111 | Naphthalene-1-sulfonic acid [2-(4-{...)
Affinity DataIC50:  66nMAssay Description:Inhibition of 125 I-PYY binding to human Neuropeptide Y receptor type 5More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110408(CHEMBL165506 | Naphthalene-1-sulfonic acid {2-[4-(...)
Affinity DataIC50:  66nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110421(CHEMBL165556 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  68nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110410(CHEMBL162094 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  72nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110412(CHEMBL159450 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  79nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110411(CHEMBL163470 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  85nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110413(CHEMBL351082 | Naphthalene-1-sulfonic acid [2-(3-{...)
Affinity DataIC50:  86nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110405(CHEMBL164748 | Naphthalene-1-sulfonic acid (2-{3-[...)
Affinity DataIC50:  140nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110404(CHEMBL350379 | Naphthalene-1-sulfonic acid (2-{3-[...)
Affinity DataIC50:  190nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110409(CHEMBL348806 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  210nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110422(CHEMBL164805 | Naphthalene-1-sulfonic acid (2-{3-[...)
Affinity DataIC50:  310nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110406(CHEMBL164971 | Naphthalene-1-sulfonic acid (1-{2-[...)
Affinity DataIC50:  540nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110420(CHEMBL349386 | [8-({1-[2-(Naphthalene-1-sulfonylam...)
Affinity DataIC50:  680nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110419(CHEMBL167318 | Naphthalene-1-sulfonic acid {1-[2-(...)
Affinity DataIC50:  740nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110423(CHEMBL166315 | Naphthalene-1-sulfonic acid {1-[2-(...)
Affinity DataIC50: >1.00E+3nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110418(CHEMBL167926 | Naphthalene-1-sulfonic acid {1-[2-(...)
Affinity DataIC50:  1.00E+3nMAssay Description:Concentration that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y5 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110415(CHEMBL164897 | Naphthalene-1-sulfonic acid (4-{[(1...)
Affinity DataIC50:  1.30E+3nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110406(CHEMBL164971 | Naphthalene-1-sulfonic acid (1-{2-[...)
Affinity DataIC50:  2.80E+3nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110411(CHEMBL163470 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  8.50E+3nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110416(CHEMBL350620 | FR-226928 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  9.50E+3nMAssay Description:Compound was evaluated for the inhibitory activity against human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110416(CHEMBL350620 | FR-226928 | Naphthalene-1-sulfonic ...)
Affinity DataIC50:  9.60E+3nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110562(5-Chloro-3-(2-{4-[(3-methoxy-6,7,8,9-tetrahydro-5H...)
Affinity DataIC50:  1.20E+4nMAssay Description:Compound was evaluated for the inhibitory activity against human Neuropeptide Y receptor type 1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110407(CHEMBL162093 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  1.40E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110412(CHEMBL159450 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  1.50E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110421(CHEMBL165556 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  1.70E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110410(CHEMBL162094 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  1.80E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110419(CHEMBL167318 | Naphthalene-1-sulfonic acid {1-[2-(...)
Affinity DataIC50:  1.90E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110413(CHEMBL351082 | Naphthalene-1-sulfonic acid [2-(3-{...)
Affinity DataIC50:  2.20E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110417(CHEMBL351508 | Naphthalene-1-sulfonic acid (2-{4-[...)
Affinity DataIC50:  2.90E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Fujisawa Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50110408(CHEMBL165506 | Naphthalene-1-sulfonic acid {2-[4-(...)
Affinity DataIC50:  3.50E+4nMAssay Description:Concentration of the compound that inhibited 50% of total specific binding of [125I]-PYY ligand to human NPY-Y1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed